LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Epidemiología de la neumonía neumocócica en adultos mayores de 50 años

    Olga Ochoa-Gondar / Verónica Torras-Vives / Cinta de Diego-Cabanes / Eva Satué Gracia / María José Forcadell-Peris / Ángel Vila-Córcoles

    Atención Primaria, Vol 55, Iss 7, Pp 102631- (2023)

    estudio de cohortes en Cataluña, 2017-2018

    2023  

    Abstract: Resumen: Objetivo: Analizar la incidencia y letalidad de la neumonía neumocócica (NN) en adultos tras la implementación de la vacunación universal en los niños. Diseño: Estudio de cohortes de base poblacional. Emplazamiento: Atención primaria/hospital, ... ...

    Abstract Resumen: Objetivo: Analizar la incidencia y letalidad de la neumonía neumocócica (NN) en adultos tras la implementación de la vacunación universal en los niños. Diseño: Estudio de cohortes de base poblacional. Emplazamiento: Atención primaria/hospital, Cataluña. Participantes: 2.059.645 personas ≥ 50 años afiliadas al Institut Català de la Salut, con seguimiento retrospectivo entre 01/01/2017-31/12/2018. Mediciones principales: El Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP) de Cataluña fue usado para establecer las características basales de los miembros de la cohorte, clasificados en 3 estratos de riesgo: bajo (inmunocompetentes sin condiciones de riesgo), medio (inmunocompetentes con alguna condición de riesgo) y alto (inmunocompromiso/asplenia). La ocurrencia de NN entre los miembros de la cohorte fue identificada mediante Conjunto Mínimo Básico de Datos de los 64 hospitales catalanes de referencia. Resultados: Se registraron 3592 episodios de NN, con una incidencia de 90,7 casos por 100.000 personas-año (IC 95%: 85,2-96,5), siendo 11,9 bacteriémicas (IC 95%: 10,8-13,1) y 78,8 no bacteriémicas (IC 95%: 74,0-83,8). La incidencia aumentó sustancialmente según edad (37,3 en 50-64; 98,3 en 65-79 y 259,8 en ≥ 80 años) y estrato de riesgo basal (42,1; 120,7 y 238,6 en bajo, medio y alto riesgo, respectivamente). La letalidad global fue del 7,6% (10,8% en casos invasivos vs. 7,1%en no invasivos; p = 0,004). En modelos multivariantes, estrato de riesgo alto y edad avanzada (> 80 años) fueron los más fuertes predictores para padecer episodios invasivos y no invasivos, respectivamente. Conclusión: La incidencia y letalidad de la NN fue moderada en la población > 50 años de Cataluña durante 2017-2018. Abstract: Objective: To analyse population-based incidence and lethality of pneumococcal pneumonia (PP) requiring hospitalisation among Catalonian adults after universal vaccination implementation in infants. Design: Population-based cohort study. Setting: Primary ...
    Keywords Adults ; Epidemiology ; Incidence ; Mortality ; Pneumococcal pneumonia ; Streptococcus pneumoniae ; Medicine (General) ; R5-920
    Language Spanish
    Publishing date 2023-07-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  2. Article ; Online: Echocardiography and Electrocardiography in Detecting Atrial Cardiomyopathy

    Delicia Gentille-Lorente / Alba Hernández-Pinilla / Eva Satue-Gracia / Eulalia Muria-Subirats / Maria Jose Forcadell-Peris / Jorge Gentille-Lorente / Juan Ballesta-Ors / Francisco Manuel Martín-Lujan / Josep Lluis Clua-Espuny

    Journal of Clinical Medicine, Vol 12, Iss 23, p

    A Promising Path to Predicting Cardioembolic Strokes and Atrial Fibrillation

    2023  Volume 7315

    Abstract: 1) Background: Atrial cardiomyopathy constitutes an intrinsically prothrombotic atrial substrate that may promote atrial fibrillation and thromboembolic events, especially stroke, independently of the arrhythmia. Atrial reservoir strain is the ... ...

    Abstract (1) Background: Atrial cardiomyopathy constitutes an intrinsically prothrombotic atrial substrate that may promote atrial fibrillation and thromboembolic events, especially stroke, independently of the arrhythmia. Atrial reservoir strain is the echocardiography marker with the most robust evidence supporting its prognostic utility. The main aim of this study is to identify atrial cardiomyopathy by investigating the association between left atrial dysfunction in echocardiography and P-wave abnormalities in the surface electrocardiogram. (2) Methods: This is a community-based, multicenter, prospective cohort study. A randomized sample of 100 patients at a high risk of developing atrial fibrillation were evaluated using diverse echocardiography imaging techniques, and a standard electrocardiogram. (3) Results: Significant left atrial dysfunction, expressed by a left atrial reservoir strain < 26%, showed a relationship with the dilation of the left atrium ( p < 0.001), the left atrial ejection fraction < 50% ( p < 0.001), the presence of advanced interatrial block ( p = 0.032), P-wave voltage in lead I < 0.1 mV ( p = 0.008), and MVP ECG score ( p = 0.036). (4) Conclusions: A significant relationship was observed between left atrial dysfunction and the presence of left atrial enlargement and other electrocardiography markers; all of them are non-invasive biomarkers of atrial cardiomyopathy.
    Keywords atrial cardiomyopathy ; atrial fibrillation ; interatrial block ; advanced interatrial block ; Bayés’s Syndrome ; atrial strain ; Medicine ; R
    Subject code 616
    Language English
    Publishing date 2023-11-01T00:00:00Z
    Publisher MDPI AG
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: Development of a predictive prognostic rule for early assessment of COVID-19 patients in primary care settings

    Angel Vila-Corcoles / Eva Satue-Gracia / Angel Vila-Rovira / Cinta de Diego-Cabanes / Maria Jose Forcadell-Peris / Olga Ochoa-Gondar

    Atención Primaria, Vol 53, Iss 9, Pp 102118- (2021)

    2021  

    Abstract: Objective: To investigate possible early prognostic factors among middle-aged and older adult and explore prognostic rules stratifying risk of patients. Design: Community-based retrospective cohort. Setting: Primary Health Care Tarragona region. ... ...

    Abstract Objective: To investigate possible early prognostic factors among middle-aged and older adult and explore prognostic rules stratifying risk of patients. Design: Community-based retrospective cohort. Setting: Primary Health Care Tarragona region. Participants: 282 community-dwelling symptomatic patients ≥50 years with laboratory-confirmed COVID-19 (hospitalised and/or outpatient) during March-June 2020 in Tarragona (Southern Catalonia, Spain). Main outcome measurements: Relationship between demographics, pre-existing comorbidities and early symptomatology (first 5-days) and risk of suffering critical outcome (ICU-admission/death) across clinical course was evaluated by logistic regression analyses, and simple predictive models were developed. Results: Of the 282 cases (mean age: 65.9 years; 140 men), 154 (54.6%) were hospitalised (30 ICU-admitted) and 45 (16%) deceased. Median time follow-up in clinical course was 31 days (range: 30–150) for survivors and 14 days (range: 1–81) for deceased patients. In crude analyses, increasing age, male sex, some comorbidities (renal, respiratory or cardiac disease, diabetes and hypertension) and symptoms (confusion, dyspnoea) were associated with an increased risk to suffer critical outcome, whereas other symptoms (rinorrhea, myalgias, headache, anosmia/disgeusia) were related with reduced risk. After multivariable-adjustment only age/years (OR: 1.04; 95% CI: 1.01–1.07; p = 0.004), confusion (OR: 5.33; 95% CI: 1.54–18.48; p = 0.008), dyspnoea (OR: 5.41; 95% CI: 2.74–10.69; p < 0.001) and myalgias (OR: 0.30; 95% CI: 0.10–0.93; p = 0.038) remained significantly associated with increased or reduced risk. A proposed CD65-M prognostic rule (acronym of above mentioned 4 variables) showed a good correlation with the risk of suffering critical outcome (area under ROC curve: 0.828; 95% CI: 0.774–0.882). Conclusion: Clinical course of COVID-19 is early unpredictable, but simple clinical tools as the proposed CD65-M rule (pending external validation) may be helpful assessing these ...
    Keywords COVID-19 ; Comorbilidades ; Mortalidad ; Síntomas ; Pronóstico ; Medicine (General) ; R5-920
    Language Spanish
    Publishing date 2021-11-01T00:00:00Z
    Publisher Elsevier
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: COVID19-related and all-cause mortality risk among middle-aged and older adults across the first epidemic wave of SARS-COV-2 infection

    Angel Vila-Corcoles / Eva Satue-Gracia / Angel Vila-Rovira / Cinta de Diego-Cabanes / Maria Jose Forcadell-Peris / Immaculada Hospital-Guardiola / Olga Ochoa-Gondar / Josep Basora-Gallisa

    BMC Public Health, Vol 21, Iss 1, Pp 1-

    a population-based cohort study in Southern Catalonia, Spain, March–June 2020

    2021  Volume 15

    Abstract: Abstract Background Direct and indirect COVID19-related mortality is uncertain. This study investigated all-cause and COVID19-related deaths among middle-aged and older adults during the first wave of COVID-19 pandemic period, assessing mortality risks ... ...

    Abstract Abstract Background Direct and indirect COVID19-related mortality is uncertain. This study investigated all-cause and COVID19-related deaths among middle-aged and older adults during the first wave of COVID-19 pandemic period, assessing mortality risks by pre-existing socio-demographic and medical underlying conditions. Methods Population-based cohort study involving 79,083 individuals ≥50 years-old in Tarragona (Southern Catalonia, Spain). Baseline cohort characteristics (age/sex, comorbidities and medications/vaccinations history) were established at study start (01/03/2020) and main outcomes were COVID19-related deaths (those occurred among patients with laboratory-confirmed COVID19) and all-cause deaths occurred among cohort members between 01/03/2020–30/06/2020. Mortality risks were assessed by Cox regression analyses. Results Cohort members were followed for 1,356,358 persons-weeks, occurring 576 all-cause deaths (124 COVID19-related deaths). Of the 124 deceased patients with a laboratory-confirmed COVID19, 112 (90.3%) died by (due to) COVID-19, while 12 (9.7%) died with COVID-19 (but likely due to other concomitant causes). All-cause mortality rate among cohort members across study period was 42.5 deaths per 100,000 persons-week, being 22.8 among healthy/unrelated-COVID19 subjects, 236.4 in COVID19-excluded/PCR-negative subjects, 493.7 in COVID19-compatible/PCR-unperformed subjects and 4009.1 in COVID19-confirmed patients. Increasing age, sex male, nursing-home residence, cancer, neurologic, cardiac or liver disease, receiving diuretics, systemic corticosteroids, proton-pump inhibitors and benzodiazepines were associated with increased risk of all-cause mortality; conversely, receiving renin-angiotensin inhibitors and statins were associated with reduced risk. Age/years (hazard ratio [HR]: 1.08; 95% confidence interval [CI]: 1.06–1.10), sex male (HR: 1.82; 95% CI: 1.24–2.70), nursing-home residence (HR: 12.56; 95% CI: 8.07–19.54) and number of pre-existing comorbidities (HR: 1.14; 95% CI: 1.01–1.29) were ...
    Keywords Coronavirus ; SARS-COV-2 ; COVID19 ; Mortality ; Risk ; Public aspects of medicine ; RA1-1270
    Subject code 610
    Language English
    Publishing date 2021-10-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top